Analytical Development & Quality Research
Successful biologics development relies on comprehensive analytical characterization and quality research to ensure product identity, purity, potency, stability, and consistency throughout the product lifecycle. At Protheragen, our Analytical Development & Quality Research services provide integrated analytical strategies that support biologics from early discovery through clinical development and commercial manufacturing. Combining advanced analytical technologies with extensive regulatory knowledge, we help clients establish scientifically sound analytical methods, characterize critical quality attributes (CQAs), demonstrate product comparability, and evaluate biosimilarity according to international regulatory expectations.
Overview of Analytical Development & Quality Research
Analytical Development & Quality Research are fundamental components of biologics development, providing the scientific foundation for product characterization, process optimization, quality control, and regulatory compliance. Throughout the development lifecycle, comprehensive analytical studies enable developers to understand the structural, physicochemical, and functional properties of biologic molecules while ensuring product consistency, safety, efficacy, and manufacturing robustness.
Unlike small-molecule drugs, biologics are highly complex macromolecules whose quality attributes can be influenced by cell line selection, manufacturing processes, formulation conditions, and storage environments. Therefore, a comprehensive analytical strategy is essential for identifying critical quality attributes (CQAs), monitoring process-related and product-related impurities, evaluating stability, and supporting process changes or technology transfer.
Fig.1 Bioprocess train with multiple stages of development during biosimilar manufacturing. (Nupur N, et al., 2022)
Why Analytical Development Matters
High-quality analytical data provides the scientific foundation for successful biologics development.
Comprehensive characterization confirms product identity, purity, potency, and consistency throughout development and manufacturing.
- Support Process Development
Analytical insights guide upstream and downstream optimization while identifying critical quality attributes.
Well-designed analytical strategies provide the evidence required for regulatory review and approval.
- Accelerate Biosimilar Development
Comprehensive similarity assessment shortens development timelines and supports global biosimilar submissions.
- Enable Commercial Manufacturing
Robust analytical methods ensure long-term quality control and lifecycle management after commercialization.
Our Services
We provide end-to-end process development covering every critical stage of biologics manufacturing.
Biologics Product Characterization
Comprehensive molecular and functional characterization establishes a detailed understanding of product quality, structure, and biological activity.
Our characterization studies evaluate the physicochemical and biological properties of therapeutic proteins throughout development, supporting process optimization, regulatory submissions, and manufacturing consistency.
Biologics Quality & Comparability Studies
Manufacturing changes inevitably occur during biologics development, making comparability assessment essential for demonstrating product consistency.
Our quality research team performs comprehensive analytical comparisons to evaluate the impact of manufacturing process changes, scale-up activities, technology transfer, and formulation modifications.
Biosimilar & Similarity Assessment
Successful biosimilar development requires extensive analytical comparison with the reference product.
Protheragen provides scientifically rigorous biosimilarity assessment strategies that evaluate structural, physicochemical, and functional similarity using state-of-the-art analytical technologies.
Technologies & Analytical Capabilities
Our analytical laboratories integrate multiple orthogonal analytical techniques to provide comprehensive characterization of biologic products.
| Analytical Category |
Key Technologies & Applications |
| Structural Characterization |
LC-MS/MS, Peptide Mapping, Intact Mass Analysis, Amino Acid Sequencing, Higher-Order Structure Characterization |
| Physicochemical Characterization |
SEC, IEX, CE-SDS, icIEF, Molecular Weight Determination, Aggregate Analysis |
| Functional Characterization |
SPR, ELISA, Cell-Based Potency Assays, Binding Affinity Analysis, Bioactivity Evaluation |
| Quality Testing |
Stability Studies, Comparability Studies, Method Development, Method Validation, Release Testing |
Supported Molecule Types
Our analytical development platform supports a broad range of biologic modalities, including:
Monoclonal Antibodies (mAbs)
Bispecific Antibodies
Recombinant Proteins
Fusion Proteins
Antibody-Drug Conjugates (ADCs)
Cytokines
Enzymes
Growth Factors
Vaccines
Biosimilars
Novel Protein Therapeutics
And more
Why Choose Protheragen
Protheragen combines analytical science, quality research, process development, and manufacturing expertise into a fully integrated biologics CDMO platform. Through the complementary capabilities of our strategic partners, we provide end-to-end analytical support that helps clients accelerate development while maintaining the highest standards of product quality and regulatory compliance.
Our advantages include:
- Comprehensive analytical development throughout the product lifecycle
- Advanced structural and functional characterization capabilities
- Integrated support for process development and manufacturing
- Extensive experience in comparability and biosimilar assessment
- Regulatory-oriented analytical strategies developed in accordance with applicable FDA, EMA, and ICH guidelines.
- Cross-functional scientific teams with expertise in biologics, analytical chemistry, and quality research
- Flexible solutions tailored to early discovery, clinical development, and commercial manufacturing
At Protheragen, we believe that robust analytical science is the foundation of successful biologics development. Our integrated analytical development and quality research solutions help clients understand their products, control manufacturing variability, and generate the high-quality data required for global regulatory submissions. From early characterization to commercial quality support, we are committed to delivering reliable, science-driven analytical services that accelerate innovation and ensure product success. Ready to strengthen your biologics development with robust analytical support? Contact us to explore customized analytical development and quality research solutions tailored to your project.
Reference
- Nupur N, et al. "Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms" Biotechnol, 2022, 10.
